로딩 중…
지수 로딩 중…
한국비티비
219750· KOSDAQ· Health Care· Health Care Equipment & Services
₩2,675+1.33%
2026-11-02
Financials
Valuation Metrics
한국비티비's Market Cap is ₩350B. At end of 2025 it was ₩565B. Ranked #1931 of 2,410 in KR market (top 80%), #1205 of 1,631 on KOSDAQ (top 74%), #81 of 94 in Health Care Equipment & Services (top 86%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 35.00B KRW | KR#1,931/2,410 Sec#81/94 |
| Revenue | 26.92B KRW | KR#2,063/2,410 Sec#69/94 |
| Net Income | -7.97B KRW | KR—/2,410 Sec—/94 |
| Total Assets | 39.71B KRW | KR#2,277/2,410 Sec#80/94 |
| Net Assets | 19.76B KRW | KR#2,285/2,410 Sec#87/94 |
| Employees | 97 | KR#1,656/2,410 Sec#61/94 |
| Value | ||
| P/B | 1.77x | KR#1,921/2,410 Sec#66/94 |
| P/S | 1.30x | KR#1,621/2,410 Sec#39/94 |
| FCF Yield | -17.45% | KR—/2,410 Sec—/94 |
| Profitability | ||
| ROE | -40.35% | KR#2,235/2,410 Sec#81/94 |
| ROA | -20.08% | KR#2,235/2,410 Sec#78/94 |
| Op. Margin | -14.11% | KR#2,049/2,410 Sec#67/94 |
| Revenue Growth | -21.95% | KR#2,144/2,410 Sec#87/94 |
| Earnings Growth | -7871.53% | KR#1,347/2,410 Sec#48/94 |
| Financial Health | ||
| Debt Ratio | 100.95% | KR#1,559/2,410 Sec#79/94 |
| Total Debt | 13.00B KRW | KR#1,533/2,410 Sec#46/94 |
| FCF | -6.11B KRW | KR#1,551/2,410 Sec#52/94 |
| Cash | 2.79B KRW | KR#2,178/2,410 Sec#88/94 |
| Current Ratio | 0.85x | KR#1,887/2,410 Sec#84/94 |
| Performance | ||
| 1Y Return | -50.42% | KR#1,957/2,410 Sec#72/94 |
| 1M Return | 55.98% | KR#9/2,410 Sec#1/94 |
| From 52W High | -53.60% | KR#1,314/2,410 Sec#49/94 |
| 1Y MDD | -70.70% | KR#1,983/2,410 Sec#73/94 |
| Trading | ||
| Volume | 8,210 shares | KR#1,999/2,410 Sec#82/94 |
| Trading Value | 21.5M KRW | KR#2,080/2,410 Sec#85/94 |
| Foreign Own. | 0.00% | KR—/2,410 Sec—/94 |
| Per Share | ||
| EPS | -609 KRW | KR—/2,410 Sec—/94 |
| BPS | 1,510 KRW | KR#2,198/2,410 Sec#80/94 |
Company Info
동사는 1999년 설립되어 안티에이징 미용기기 등을 생산·판매하며 2024년 동인바이오텍을 흡수합병해 사명을 변경함. 의료기기사업과 바이오사업을 구분해 뷰티 의료기기 개발·제조·판매와 생명공학 연구용 시약 및 바이오 유통사업을 하고 있음. 동사는 해외 유통 노하우로 55개국 285개 네트워크를 구축하며 국내 1,350개 대학·연구시설·병원에 유통·서비스 제공하고 있음. 한국비티비는 1999년에 설립되었으며 경기도 성남시에 본사를 두고 있습니다.